View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
Sponsored by Enamine

Deuterium-Containing Building Blocks for Drug Design

Free White Paper

Deuterium-Containing Building Blocks for Drug Design

By Enamine

Deuterium-Containing Building Blocks for Drug Design

By Enamine
Enter your details to receive the free paper:

Selective incorporation of deuterium into organic molecules can profoundly alter their physical, chemical and biological properties.

Compared to hydrogen,deuterium displays a smaller molar volume (by 0.140 cm3/mol per atom), is less lipophilic (Δ logPoct = – 0.006) and might display a slightly different pKa. More importantly, C-D bonds are shorter (by 0.005 Å) and at times more stable to oxidative processes. This helps protect deuterated compounds from enzymatic degradation in the liver, increasing the compound’s half-life. In this context, Enamine offers a library of deuterium-containing building blocks for drug design.

We offer deuterium-containing building blocks from stock on a 5-10 g scale.

Design and full list you can find at MedChem Highlights section of Enamine’s website or in the white paper attachment on this page.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology